Targeting the KRAS G12D Mutant as Potential Therapy in Cancer
- ACS Med Chem Lett. 2021 Aug 2;12(8):1212-1213. doi: 10.1021/acsmedchemlett.1c00390.
Affiliations
- 1. Usona Institute, 277 Granada Drive, San Luis Obispo, California 93401-7337, United States.
PMID: 34413947
DOI: 10.1021/acsmedchemlett.1c00390